In vivo orthotopic breast tumor model - by Explicyte Immuno-Oncology
Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model | Nature Communications
Induction of oligoclonal CD8 T cell responses against pulmonary metastatic cancer by a phospholipid-conjugated TLR7 agonist | PNAS
Active immunotherapy for mouse breast cancer with irradiated whole-cell vaccine expressing VEGFR2
Intraductal Adaptation of the 4T1 Mouse Model of Breast Cancer Reveals Effects of the Epithelial Microenvironment on Tumor Progression and Metastasis | Anticancer Research
Rejection of Metastatic 4T1 Breast Cancer by Attenuation of Treg Cells in Combination With Immune Stimulation - ScienceDirect
Simultaneous isolation of CD45 tumor-infiltrating lymphocytes, tumor cells, and associated fibroblasts from murine breast tumor model by MACS - ScienceDirect
Bone marrow-derived, alternatively activated macrophages enhance solid tumor growth and lung metastasis of mammary carcinoma cells in a Balb/C mouse orthotopic model | Breast Cancer Research | Full Text
4T1 Mouse Model | Ichor Life Sciences
4T1 Syngeneic Murine Model - Altogen Labs
Molecules | Free Full-Text | In Vivo Anti-Tumor Effects of Citral on 4T1 Breast Cancer Cells via Induction of Apoptosis and Downregulation of Aldehyde Dehydrogenase Activity
SH inhibited breast cancer metastasis in a 4T1 metastatic mouse model.... | Download Scientific Diagram
JCI Insight - Metastasis regulation by PPARD expression in cancer cells
Breast Tumor Cells Highly Resistant to Drugs Are Controlled Only by the Immune Response Induced in an Immunocompetent Mouse Model - Paola Lasso, Mónica Llano Murcia, Tito Alejandro Sandoval, Claudia Urueña, Alfonso
Comparison of breast cancer metastasis models reveals a possible mechanism of tumor aggressiveness | Cell Death & Disease
Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model | Nature Communications
Differential Proteome Analysis Identifies TGF-β-Related Pro-Metastatic Proteins in a 4T1 Murine Breast Cancer Model | PLOS ONE
Altogen Labs 4T1 Xenograft Service Breast Cancer - YouTube
Cancers | Free Full-Text | Regression and Eradication of Triple-Negative Breast Carcinoma in 4T1 Mouse Model by Combination Immunotherapies
Combination of Propranolol and Heated 4T1 Cells Elicits Beneficial Response Against Mouse Model of Breast Cancer | Zahedan Journal of Research in Medical Sciences | Full Text
![PDF] Comparative Profiling of Metastatic 4T1- vs. Non-metastatic Py230-Based Mammary Tumors in an Intraductal Model for Triple-Negative Breast Cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/33866596c5dd8f6a4c67a517bf7074c34c75a608/5-Figure1-1.png "PDF] Comparative Profiling of Metastatic 4T1- vs. Non-metastatic Py230-Based Mammary Tumors in an Intraductal Model for Triple-Negative Breast Cancer | Semantic Scholar")
PDF] Comparative Profiling of Metastatic 4T1- vs. Non-metastatic Py230-Based Mammary Tumors in an Intraductal Model for Triple-Negative Breast Cancer | Semantic Scholar
Mammary tissue microenvironment determines T cell‐dependent breast cancer‐associated inflammation - Takahashi - 2015 - Cancer Science - Wiley Online Library
Molecular response of 4T1 induced mouse mammary tumour and healthy tissues to zinc treatment – Masarik lab
OMO-1 reduces progression and enhances cisplatin efficacy in a 4T1-based non-c-MET addicted intraductal mouse model for triple-negative breast cancer | npj Breast Cancer
Frontiers | Osteolytic Breast Cancer Causes Skeletal Muscle Weakness in an Immunocompetent Syngeneic Mouse Model
BH is effective in TNBC tumor model. On day 8, 4T1 tumor model mice... | Download Scientific Diagram
Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer | Journal of Experimental & Clinical Cancer Research | Full Text
